Enantioselective Hydrogenation of Chromenes Using Ir Catalyst

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing enantioselective equol and related chromanes are limited in terms of production rate and suitability for commercial quantities, lacking a cost-effective approach.

Innovation Solution

The method involves enantioselective hydrogenation of non-functionalized cyclic olefins, specifically chromenes, using an Ir catalyst with a chiral ligand to produce high-purity enantiomeric equol and chromanes, including the steps of providing a chromene compound, hydrogenating it in the presence of the catalyst, and optionally protecting and deprotecting hydroxyl groups to achieve the desired enantiomeric equol.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If chiral chromatographic resolution is used to isolate enantiomeric equol from racemic mixture, then enantiomeric purity is improved, but production rate and cost-effectiveness deteriorate

Engineering Contradiction:
Improveenantiomeric purityVSAvoidproduction rate
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

Instead of starting with racemic mixture and separating enantiomers through chromatographic resolution (the conventional approach), the invention inverts the approach by directly synthesizing the desired enantiomer through enantioselective hydrogenation. This eliminates the need for separation processes and achieves both high enantiomeric purity and efficient production rate simultaneously.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The invention changes the fundamental parameter of the synthesis approach from racemic synthesis followed by resolution to enantioselective synthesis. By using chiral catalysts (such as chiral organometallic complexes or enzymes) that preferentially catalyze the formation of one enantiomer, the process achieves high enantiomeric purity directly in the synthesis step, thereby improving both productivity and manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If chiral chromatographic resolution is used to isolate enantiomeric equol from racemic mixture, then enantiomeric purity is improved, but manufacturing cost deteriorates

Engineering Contradiction:
Improveenantiomeric purityVSAvoidmanufacturing cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The invention inverts the conventional workflow by eliminating the costly chromatographic resolution step. Instead of separating enantiomers after synthesis, the method directly produces the desired enantiomer through enantioselective hydrogenation, thereby reducing manufacturing costs while maintaining high enantiomeric purity.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The invention changes the synthesis parameter from non-enantioselective to enantioselective hydrogenation. By using chiral catalysts that provide high enantiomeric excess directly during synthesis, the process eliminates the need for expensive resolution procedures, thereby improving ease of manufacture and reducing costs while achieving high manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the synthesis of enantioselective equol with high enantiomeric excess, up to 99.5%, suitable for commercial quantities, improving the efficiency and cost-effectiveness of equol production.

Implementation Method 1

hydrogenating the chromene in the presence of an Ir catalyst having a chiral ligand

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Implementation Method 2

Ir catalyst having a chiral ligand shown as compound (V)

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS7528267B2Method for enantioselective hydrogenation of chromenes
Publication Date: 2009.05.05 AUSIO PHARMACEUTICALS LLC
  • US7528267B2 patent drawing
  • US7528267B2 patent drawing
  • US7528267B2 patent drawing

AI summary

A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the enantioselective preparation of enantiomeric equol. A preferred Ir catalyst has a chiral phosphineoxazoline ligand. Enantiomeric chromanes of high stereoselective purity can be obtained.